• / Free eNewsletters & Magazine
  • / My Account
Home>Video Archive

Video Archive

  1. Alibaba Investors: Mind the Risks


    Valuation on the newly minted wide-moat firm may be reasonable, but potential investors need to appreciate the key business, regulatory, and stewardship risks, says Morningstar's RJ Hottovy.

  2. 'Great Rotation' Into Stocks Runs Its Course


    Investors have been putting money back into bond funds as interest rates have unexpectedly dropped this year.

  3. Peters: Know What You Want From Dividend ETFs


    There can be good reasons to own dividend-focused ETFs, but investors looking for pure income may be better off in individual stocks, says Morningstar's Josh Peters.

  4. Where Will Growth Come From?


    With dividend yields below long-run historical norms and the market overall looking pricey, growth in companies' intrinsic values will be key for stock investors, says Morningstar's Matt Coffina.

  5. Koesterich: This Bull Market Can Survive Higher Rates


    The U.S. economy and stock market should be able to absorb a measured rise in rates starting next year, but investors should expect subsequent raises to come soon after, says BlackRock's Russ Koesterich.

  6. Carving Out a Moat in the Insurance Industry


    Morningstar analysts recently upgraded AIG's moat trend rating as the insurer improves its underwriting.

  7. Deflation? We're Not There Yet


    August may have seen the first monthly decline in overall prices this year, but several categories are still up on a year-over-year basis, says Morningstar's Bob Johnson.

  8. Schneider: Volatility Will Be a Primary Focus for Investors


    As Fed policy tightens over the short term, investors will have to actively manage interest rate exposure while looking ahead to a 'new neutral' in the next three to five years, says PIMCO's Jerome Schneider.

  9. 2 Muni Fund Picks That Sidestep Market Turbulence


    Fidelity Municipal Income and T. Rowe Price Tax-Free High Yield hold up well when muni markets head south.

  10. Kelly: Stiffer Headwinds Up Ahead


    Constrained labor force and productivity growth will add up to only 2% real growth for the U.S. economy over the long term, says J.P. Morgan's David Kelly.

  11. Friday Five: Rate Hike Hints and Alibaba Uncertainties


    Plus, the Scotland vote's lesson for investors, inflation's abatement, and more.

  12. A Favorable Prognosis for This Pharma Stock


    Recent clinical success in cystic fibrosis positions Vertex as a dominant player in this attractive rare-disease market.

1 - 12 of about 1287 Results
Upcoming Events

©2014 Morningstar Advisor. All right reserved.